The Texas Medical Center and the Department for International Trade in the United Kingdom formed a landmark BioBridge agreement Wednesday to provide a gateway for the advancement of life sciences between the two entities in the areas of innovation and research.
The BioBridge, which included more than 18 months of preparation by the government team at the British Consulate General in Houston, establishes a thriving marketplace for innovative life science technologies in the world’s largest medical city and acts as a two-way “innovation superhighway” for emerging technologies at every stage of the innovation life cycle. This will offer UK companies a unique package that will help boost exports and drive scientific innovation.
“This truly unique collaboration is a testament to the Texas Medical Center’s and the United Kingdom’s joint commitment to further fostering the cross-pollination of ideas, people and innovation in the life sciences,” William McKeon, president and CEO of TMC, said in a statement. “We believe this new relationship will serve to create a tactical alliance between TMC and a nation that has been at the forefront of substantial medical innovation for centuries.”
This is TMC’s second BioBridge; the first was formed with Australia in 2016. Since then, five startups from Australia have come to Houston to participate in the TMCx accelerator program.
Yesterday we launched a new BioBridge partnership with the @TXMedCenter that will give ?? life sciences organisations unique access into the ?? market.
— Department for International Trade (@tradegovuk) September 13, 2018
The newest BioBridge also will allow for research collaboration, particularly in the development and advancement of genomics and cancer treatments, as well as provide shared curriculum from accelerators tailored to startup companies from both countries.
“The UK-TMC BioBridge will allow British life science businesses to house themselves in the TMC Innovation Institute where they will have access to a network of advisors, investors and medical experts throughout the world’s largest medical city,” McKeon tweeted following the announcement.
Collaboration is happening already and the interaction could include possible partnerships between TMC institutions and health care trusts in the UK cities of Oxford, Cambridge and Manchester.
So far, three UK companies are involved in the BioBridge: Paxman Scalp Cooling, which specializes in cooling therapies for help breast cancer patients undergoing chemotherapy and has an office in the TMC Innovation Institute; SurePulse Medical and FirstKind Ltd. are part of the current TMCx medical device program.
“The UK is a world leader in health care innovation,” Baroness Rona Fairhead, UK Minister of State for the Department for International Trade, said in a statement. “This partnership is clear evidence of the opportunities that exist for our companies in exciting markets such as the United States.”
RT @RiceMSNE: Beating the heat in electronics: This flexible insulator from @RiceEngineering researchers offers high strength and superior…
RT @Rice_BIOE: Special congratulations to #RiceBIOE's Oleg Igoshin & Tomasz Tkaczyk who were promoted to full professors & to David Zhang w…
RT @bcm_neurosci: @TheEconomist covers the exciting work done by Dr. Mauro Costa-Mattioli, Professor in the Department of Neuroscience, foc…
What the healthcare overhaul at VA means for Alaska Vets https://t.co/FClTagi6sU via @AKPublicNews
In honor of Military Appreciation Month, we are highlighting some of the ways Baylor College of Medicine has supported the military for both active and retired members. https://t.co/j6ucDP4WRE #MilitaryAppreciationMonth
RT @UHOnlineCoogs: Looking for an online Salesforce Administrator course? We offer one with application for a variety of careers. Enroll to…
RT @UHoustonLib: Good morning, Coogs! We're open 'til 5:45 pm todayhttps://t.co/YsdnMYWN9G https://t.co/Iw4msLmPGu
Leslie Contreras Schwartz ’02 is now serving two very different roles that somehow seem appropriate for a Rice graduate:1. Editorial assistant for Tissue Engineering, a @Rice_BIOE journal.2. Houston’s newly appointed poet laureate.Read more: https://t.co/MkrfWB14Bi https://t.co/2lYwDzE66N
“We want to be able to detect a smaller amount of cancer earlier,” says our Dr. Robert Bast on a new blood test he’s developing to detect #ovariancancer at least a year earlier from the time when patients traditionally have been diagnosed. #gynsm #endcancer https://t.co/JvGcEDapvg
RT @mdvagov: Looking for something to do to serve #Veterans? Volunteer as a driver in the VeteranTransporation Network at the VA Maryland H…
@JobDavidKatytx We're sorry to hear this, James. To learn about our job openings, you can follow @MDAndersonJobs or visit our website: https://t.co/iuFMMpA423. Best of luck.
#Genetictesting can be the first step in treating hereditary cancers and saving lives.Here’s how our @karenluMD and @EMBOSU are working to screen more patients: https://t.co/Ak6Sqkz1d1 @CancerFrontline #CancerMoonshot #endcancer
RT @NCAAsoftball: Might need some more juggling lessons 😅#NCAASoftball | @UHCougarSB https://t.co/zOFdgc3mTG
One moment can inspire a Veteran to make a positive change. This #mentalhealthmonth, visit Make the Connection at https://t.co/9GSKXF21JA to hear about some of the moments that mattered most. https://t.co/IIbMvU0G1x
In honor of Better Hearing and Speech Month, Dr. Alex Sweeney discusses some of the options to make hearing loss manageable. https://t.co/a0apb5BZRC #BetterHearingandSpeechMonth